Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
Annika De Sousa Linhares(Medical University of Vienna), Peter Steinberger(University of Vienna), Gerhard J. Zlabinger(Medical University of Vienna), Christine Häfner(Karl Landsteiner University of Health Sciences), Katharina Grabmeier‐Pfistershammer, Ursula Wiedermann(Medical University of Vienna), Sabrina Jutz(Medical University of Vienna), Joshua Tobias(Medical University of Vienna), Michael Kundi(Medical University of Vienna), Judith Leitner(University of Vienna), Claire Battin(Medical University of Vienna)
Cited by 196
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review.
|PubMed|2012|531
Mpox in people with advanced HIV infection: a global case series
|The Lancet|2023|506
EUROPAEM EMF Guideline 2016 for the prevention, diagnosis and treatment of EMF-related health problems and illnesses
|Reviews on Environmental Health|2016|496
Detoxification of patulin and ochratoxin A, two abundant mycotoxins, by lactic acid bacteria
|Food and Chemical Toxicology|2007|344